SCHEMBL42248

SCHEMBL42248

[CH2]C(CCC)CCC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL56695 0.87
SCHEMBL84321 0.87
SCHEMBL4856577 0.85 TSHR (0.32)
SCHEMBL10604216 0.85
SCHEMBL27635 0.85
SCHEMBL10604210 0.85
SCHEMBL19423317 0.84
SCHEMBL22344099 0.84
SCHEMBL101545 0.84 TSHR (0.33)
SCHEMBL43692 0.84 OPRM1 (0.43)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 9497 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12030903-B2 Antiviral compounds GILEAD SCIENCES, INC. (US) 2024-07-09 US claimed
EP-3708596-B1 NOVEL METALLOCENE CATALYST COMPOUND FOR PRODUCTION OF POLYOLEFIN RESIN OR METHOD OF PREPARING SAME DL CHEMICAL CO LTD (KR) 2024-03-27 EP claimed
WO-2024027844-A1 PHARMACEUTICAL COMPOSITION AND USE THEREOF 临港国家实验室 2024-02-08 WO claimed
WO-2024002112-A1 METHOD FOR TREATING FELINE CORONAVIRUS OR CALICIVIRUS INFECTION 苏州旺山旺水生物医药股份有限公司 2024-01-04 WO claimed
CN-112105624-B Treatment of cancer using (2, 2-dihydroxymethyl) methylene cyclopropane nucleotides 美迪维尔公司 2023-09-22 CN claimed
WO-2023152709-A1 RNA POLYMERASE INHIBITORS AND METHODS USING SAME ARBUTUS BIOPHARMA CORPORATION (CA) 2023-08-17 WO claimed
CN-116514874-A Phosphorescent doped material with pyridyl aza-dibenzofuran ligand and application thereof 吉林奥来德光电材料股份有限公司 2023-08-01 CN claimed
WO-2023130008-A2 PHARMACEUTICAL COMPOSITIONS OF 6-(2-(2H-TETRAZOL-5-YL)ETHYL)DECAHYDROISOQUINOLINE-3-CARBOXYLIC ACID AND DERIVATIVES THEREOF SEA PHARMACEUTICALS LLC (US) 2023-07-06 WO claimed
US-11685726-B2 Pharmaceutical compositions of 6-(2-(2H-tetrazol-5-yl)ethyl)-6-fluorodecahydroisoquinoline-3-carboxylic acid and ester derivatives thereof SEA PHARMACEUTICALS LLC (US) 2023-06-27 US claimed
CN-116199723-A Phosphorescent doped material with pyridyl aza-dibenzofuran ligand and application thereof 吉林奥来德光电材料股份有限公司 2023-06-02 CN claimed
EP-0107759-B1 CYCLOHEXANE DERIVATIVES AND THEIR USE AS COMPONENTS FOR LIQUID CRYSTALS MERCK PATENT GmbH (DE) 1992-12-16 EP claimed
US-5155220-A Simplified production of plaque inhibitor KABI PHARMACIA AKTIEBOLAG (SE) 1992-10-13 US claimed
EP-0426826-A1 SUBSTITUTED ISOXAZOLIDINES AND ISOXAZOLINES. PHARMACIA AB (SE) 1991-05-15 EP claimed
WO-1990014342-A1 SUBSTITUTED ISOXAZOLIDINES AND ISOXAZOLINES PHARMACIA AB (SE) 1990-11-29 WO claimed
US-4894181-A Carbocyclic compounds MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 1990-01-16 US claimed
US-4758373-A Carbocyclic compounds MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 1988-07-19 US claimed
US-4707295-A LIQUID CRYSTALS, DISPLAYS MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 1987-11-17 US claimed
US-4399147-A Prostaglandin 12 analogues and their pharmaceutical compositions ONO PHARMACEUTICAL CO. LTD. (JP) 1983-08-16 US claimed
US-4235875-A ALKYL 1-(HYDROXYALKYL)PIPERIDINES A.B. FERROSAN (SE) 1980-11-25 US claimed
US-4207332-A Prostaglandin I2 analogues ONO PHARMACEUTICAL CO., LTD. (JP) 1980-06-10 US claimed